Lupin Sharpens Focus With Carve-Out Of Indian Trade Generics Business
Indian Firm Looks To Achieve ‘Agility, Better Focus And Growth’ With Transaction
Lupin has announced plans to carve out its trade generics business in India to its Lupin Life Sciences Limited subsidiary, as part of efforts to achieve “agility, better focus and growth” for the unit.
